DVA

DaVita

Halal Rating :
Uncomfortable
Last Price $166.28 Last updated:
Market Cap $12.86b
7D Change 5.87%
1 Year Change 58.92%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Services
  • Healthcare
  • Services – Health
Exchange NYSE
Next Earnings Date Nov. 7, 2024

DaVita Inc. is a healthcare company that provides kidney dialysis services for patients suffering from chronic kidney failure and end-stage renal disease. The company operates dialysis centers and provides related lab services in the United States. They also operate internationally through various subsidiaries, providing dialysis services in several countries.

The company focuses on providing dialysis services, coordinated care, comprehensive outpatient and inpatient services, as well as chronic kidney disease management. DaVita also offers various ancillary services and strategic initiatives, including pharmacy services, disease management services, and clinical research programs.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $3.26b $2.87b - $144.66m 0.00% 5.03%
June 30, 2024 $3.19b $2.79b - $107.48m 0.00% 3.86%
March 31, 2024 $3.07b $2.69b - $99.42m 0.00% 3.70%

Company Impact

Help us evaluate DaVita's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates